Volumizing effect of a new hyaluronic acid sub‐dermal facial filler: A retrospective analysis based on 102 cases

Abstract

Introduction: Many signs of aging are due to the loss of subcutaneous fat. Dermal fillers are non‐surgical cosmetic treatments used to restore facial volume. Voluma® is a new hyaluronic acid sub‐dermal facial filler. The objective of this study was to assess its effectiveness in maintaining increased volume for up to 18 months post‐treatment and its safety. Methods: Retrospective record analysis was made for 102 patients (93 females, nine males; mean age: 51.27 years) who received Voluma injected into the midface. All patients were assessed at baseline and at 1 month and 6–18 months post‐injection. Results: Investigator Global Aesthetic Improvement assessment after 1 month and 6–18 months showed that most patients were ‘much’ or ‘very much’ improved. Investigator volume loss assessment confirmed that most patients were either stage 1 or 2 (normal or slight ptosis) 1 month post‐treatment, which was maintained at 6–18 months. Patient efficacy assessment was ‘very good’ or ‘good’ in most cases. Conclusions: Voluma provides aesthetic improvements according to investigator and patient assessment for up to 18 months post‐treatment. Combination treatment comprising facial fillers and botulinum neurotoxin can enhance treatment benefits. Further methodologically rigorous studies are required to establish the performance of Voluma alone and in combination.

• Hyaluronic acid
• Juvéderm Voluma®
• midface
• sub‐dermal facial filler
• tridimensional facial rejuvenation (3D)
• Voluma®